Check out the latest articles in our Investment Trusts portal

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTakeda Pharm Or Regulatory News (0RN3)

Share Price Information for Takeda Pharm Or (0RN3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.953
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 35.953
Low: 35.953
Yest. Close: 35.953
0RN3 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

FORM 8.3 - TAKEDA PHARMACEUTICAL CO LTD

Fri, 28th Sep 2018 13:03

LONDON--(BUSINESS WIRE)--

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)   Full name of discloser:   Barclays PLC.
     
(b) Owner or controller of interest and short
  positions disclosed, if different from 1(a):  
(c) Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
  relevant securities this form relates:  
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
  offeror/offeree:  
(e) Date position held/dealing undertaken: 27 September 2018
(f) In addition to the company in 1(c) above, is the discloser making YES:
  disclosures in respect of any other party to the offer? SHIRE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:       Ordinary NPV            
Interests Short Positions
    Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 11,068,799 1.39% 11,959,262 1.50%
           
(2) Cash-settled derivatives:
11,453,318 1.44% 10,388,702 1.31%
           
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 10,569,600 1.33% 10,989,600 1.38%
           
 
TOTAL: 33,091,717 4.16% 33,337,564 4.19%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant   Purchase/sale   Number of   Price per unit
security   securities  
ADR Purchase 7,379 21.6490 USD
ADR Purchase 10,400 21.5813 USD
ADR Sale 1,900 21.6873 USD
ADR Sale 5,479 21.6357 USD
ADR Sale 10,400 21.5813 USD
Ordinary NPV Purchase 100 4,898.0000 JPY
Ordinary NPV Purchase 100 4,886.5000 JPY
Ordinary NPV Purchase 1,000 4,867.5000 JPY
Ordinary NPV Purchase 1,200 4,855.0000 JPY
Ordinary NPV Purchase 1,600 4,862.4375 JPY
Ordinary NPV Purchase 1,700 4,873.3529 JPY
Ordinary NPV Purchase 2,500 4,865.5600 JPY
Ordinary NPV Purchase 2,600 4,882.2692 JPY
Ordinary NPV Purchase 3,600 4,865.9166 JPY
Ordinary NPV Purchase 4,600 4,906.0000 JPY
Ordinary NPV Purchase 5,700 4,862.1719 JPY
Ordinary NPV Purchase 5,800 4,873.9068 JPY
Ordinary NPV Purchase 6,500 4,899.5384 JPY
Ordinary NPV Purchase 7,000 4,861.6500 JPY
Ordinary NPV Purchase 7,500 4,870.8533 JPY
Ordinary NPV Purchase 8,000 4,896.4125 JPY
Ordinary NPV Purchase 11,700 4,832.6666 JPY
Ordinary NPV Purchase 13,400 4,871.2014 JPY
Ordinary NPV Purchase 30,000 4,852.4633 JPY
Ordinary NPV Purchase 49,800 4,898.0562 JPY
Ordinary NPV Purchase 51,100 4,849.8297 JPY
Ordinary NPV Purchase 80,700 4,885.9913 JPY
Ordinary NPV Purchase 371,200 4,867.4789 JPY
Ordinary NPV Purchase 553,100 4,868.1229 JPY
Ordinary NPV Purchase 602,400 4,869.9721 JPY
Ordinary NPV Sale 100 4,894.0000 JPY
Ordinary NPV Sale 300 4,851.3333 JPY
Ordinary NPV Sale 700 4,852.2857 JPY
Ordinary NPV Sale 800 4,800.5000 JPY
Ordinary NPV Sale 1,000 4,867.5000 JPY
Ordinary NPV Sale 1,200 4,855.0000 JPY
Ordinary NPV Sale 1,600 4,862.4375 JPY
Ordinary NPV Sale 2,500 4,865.5600 JPY
Ordinary NPV Sale 3,600 4,857.5277 JPY
Ordinary NPV Sale 4,300 4,804.0000 JPY
Ordinary NPV Sale 5,200 4,875.6019 JPY
Ordinary NPV Sale 5,700 4,862.1719 JPY
Ordinary NPV Sale 6,500 4,862.3692 JPY
Ordinary NPV Sale 7,600 4,871.0592 JPY
Ordinary NPV Sale 12,700 4,844.3937 JPY
Ordinary NPV Sale 13,300 4,827.2105 JPY
Ordinary NPV Sale 17,100 4,895.4502 JPY
Ordinary NPV Sale 48,800 4,897.2541 JPY
Ordinary NPV Sale 51,100 4,849.2622 JPY
Ordinary NPV Sale 54,100 4,899.0000 JPY
Ordinary NPV Sale 222,700 4,877.0431 JPY
Ordinary NPV Sale 291,300 4,853.9783 JPY
Ordinary NPV Sale 553,100 4,868.1229 JPY
Ordinary NPV Sale 553,600 4,867.5671 JPY

(b) Cash-settled derivative transactions

Class of   Product   Nature of dealing   Number of   Price per
relevant description reference unit
security     securities  
Ordinary NPV SWAP Long 200 4,865.0000 JPY

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security   Product description e.g. call option   Writing, purchasing, selling, varying etc.   Number of securities to which option relates   Exercise price per unit   Type

e.g. American, European etc.

  Expiry date   Option money paid/ received per unit

(ii) Exercise

Class of relevant security   Product description

e.g. call option

  Exercising/ exercised against   Number of securities   Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security   Nature of dealing

e.g. subscription, conversion

  Details   Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?   YES
Date of disclosure: 28 Sep 2018
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Identity of the person whose positions/dealings   Barclays PLC.
are being disclosed:  
Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this from relates:  

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class   Product   Writing,   Number   Exercise   Type   Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
      relates      
Ordinary NPV Call Options Purchased 39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Purchased 40,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Purchased 48,000 4625.0000 European 12 Oct 2018
Ordinary NPV Call Options Purchased 82,000 5264.7000 European 25 Oct 2018
Ordinary NPV Call Options Written -460,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Written -104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Call Options Written -78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Call Options Written -70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Purchased -48,000 4625.0000 European 12 Oct 2018
Ordinary NPV Put Options Purchased -39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Written 75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Put Options Written 78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Put Options Written 114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Purchased 10,000,000 4528.6397 European 5 Oct 2018
Ordinary NPV Call Options Written -10,000,000 4528.6397 European 5 Oct 2018
Ordinary NPV Put Options Purchased -10,000,000 4528.6397 European 5 Oct 2018
Ordinary NPV Put Options Written 10,000,000 4528.6397 European 5 Oct 2018

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180928005232/en/

BARCLAYS PLC

Source: BARCLAYS PLC

Login to your account

Don't have an account? Click here to register.